Background Pandemic COVID-19 by severe acute respiratory syndrome (SARS)
coronavirus 2 (SARS-CoV-2) infection is facilitated by the ACE2 receptor and protease …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global
pandemic. One open question is whether genetics could influence the severity of symptoms …

Little is known of the patterns of expression of ACE2 and TMPRSS2 or the clinical
characteristics of COVID-19 in patients with COVID-19 and colorectal cancer. We found in …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected more than
29 million people and has caused more than 900,000 deaths worldwide as of September …

Introduction Coronavirus disease 2019 is an infectious disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), which enters host cells through the cell …

Severe acute respiratory syndrome (SARS) coronavirus‑2 (SARS‑CoV2) is the cause of a
new disease (COVID‑19) which has evolved into a pandemic during the first half of 2020 …

Recent retrospective studies of severe acute respiratory syndrome coronavirus 2 (SARS‐
CoV‐2) disease (COVID‐19) revealed that the patients with common comorbidities of …

Abstract The novel coronavirus (2019-nCoV) is an emerging causative agent that was first
described in late December 2019 and causes a severe respiratory infection in humans …

Background: Angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease
2 (TMPRSS2) allow entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV …

Background Since December 2019, the novel coronavirus, severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), first spread quickly in Wuhan, China, then globally …